1.Minimally invasive percutaneous plate osteosynthesis versus open reduction and internal fixation for distal tibial fractures in adults: a meta-analysis.
Qing-xi ZHANG ; Fu-qiang GAO ; Wei SUN ; Yun-ting WANG ; Yu-run YANG ; Zirong LI
China Journal of Orthopaedics and Traumatology 2015;28(8):757-762
OBJECTIVETo perform a meta-analysis on clinical outcomes of minimally invasive percutaneous plate osteosynthesis (MIPPO) or open reduction and internal fixation (ORIF) for distal tibial fractures in adults.
METHODSPubmed database (from 1968 to March 2014), Cochrane library and CNKI database (from 1998 to March 2014) were searched. Case-control study on minimally invasive percutaneous plate osteosynthesis (MIPPO) or open reduction and internal fixation (ORIF) for distal tibial fractures in adults were chosen,and postoperative infection, operative time, blood loss, fracture nonunion rate, delayed union,fracture malunion rate were seen as evaluation index for meta analysis. The system review was performed using the method recommended by the Cochrane Collaboration.
RESULTSTotally 5 studies (366 patients) were enrolled. Meta-analysis showed that there were significant meaning in postoperative infection between MIPPO and ORIF [OR = 0.23,95% CI (0.06,0.92), P = 0.04]; fracture nonunion rate in MIPPO was lower than in ORIF group [OR = 0.16, 95% CI (0.03,0.76), P = 0.02]; operative time in MIPPO was shorter than in ORIF group, and had significant difference [MD = -14.42, 95% CI (-27.79, -1.05), P < 0.05]; blood loss in MIPPO was less than in ORIF group [MD= -87.17,95%CI (-99.20, -75.15), P < 0.05]; there was no obviously meaning in delayed union between two groups.
CONCLUSIONFor distal tibial fractures in adults, MIPPO has, advantages of short operative time, less blood loss, lower incidence of infection and fracture non-uniom, but with high fracture malunion rate. MIPPO for distal tibial fractures in adults is better than ORIF, and the best treatment should choose according to patient's condition.
Bone Plates ; Fracture Fixation, Internal ; methods ; Fracture Healing ; Humans ; Minimally Invasive Surgical Procedures ; methods ; Operative Time ; Tibial Fractures ; surgery
2.Study on the relationship between microsatellite alterations of RASSF1A gene and the development of cervical carcinoma.
Fu-xi ZHAO ; Jie YAN ; Run-hua LIU ; Xi-ying WANG ; Li-hua LIU
Chinese Journal of Experimental and Clinical Virology 2008;22(5):345-347
OBJECTIVETo explore the relationship between microsatellite alterations of RASSF1A gene and the development of cervical carcinoma, and HPV16 infection.
METHODSTwo sites of microsatellite polymorphism of RASSF1A gene were selected, we used polymerase chain reaction (PCR) technique to detect the LOH and MSI of cervical tissues, and to detect the infection state of HPV16.
RESULTSThere were significant differences of LOH rates at the two sites between clinical stage and pathological grade (P < 0.05). Significant differences were noted between the cervical carcinomas with lymph node metastasis and those without lymph node metastasis in regard to their LOH and MSI at the two sites ( P < 0.05). The incidence of LOH of RASSF1A gene was higher in HPV16(+) than that in HPV16(-) ( P < 0.05).
CONCLUSIONThe change of RASSF1A gene is a relatively late event in cervical carcinomas. The detection of the LOH and MSI of RASSF1A gene might be helpful to the early diagnosis and the screening of cervical carcinoma. It might also be useful for predicting the prognosis of cervical carcinoma. Infection of HPV16 and LOH of RASSF1A gene had reacted together in the development of cervical carcinoma.
Cervical Intraepithelial Neoplasia ; diagnosis ; genetics ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Loss of Heterozygosity ; genetics ; Microsatellite Repeats ; genetics ; NM23 Nucleoside Diphosphate Kinases ; genetics ; Tumor Suppressor Proteins ; genetics ; Uterine Cervical Neoplasms ; diagnosis ; genetics
3.Effect of blockage of costimulatory signal on murine abortion-prone model.
Fu-Xi ZHAO ; Yuan-Yuan ZHANG ; Run-Hua LIU ; Shuan-Ming LI
Chinese Medical Journal 2007;120(14):1247-1250
BACKGROUNDInhibition of the key costimulatory signals results in T cell anergy, indicating the alloantigen-specific immunologic unresponsiveness. In this study, the effect of blockage of costimulatory signal CD(86) on murine abortion-prone model was studied.
METHODSThirty CBA/J female mice cohabitated with DBA/2 male or BALB/c male mice were investigated. CBA/J x DBA/2 matings were used as the abortion-prone model, and CBA/J x BALB/c matings were used as the normal pregnant model. The abortion-prone models were divided into experimental and control groups, and the normal pregnant models were set as a normal group (10 mice in each group). The mice in the experimental group were treated with anti-mouse CD(86) monoclonal antibody (mAb) (100 microg) on day 4.5 of gestation, while the controls received irrelevant-isotype matched rat IgG(2b). As for the normal group, nothing was given to the mice. The mice were killed on day 13.5 of gestation, embryo resorption rate and the expression of transforming growth factor beta(1) (TGF-beta(1)), plasminogen activator inhibitor 1 (PAI-1), and matrix metalloproteinase 9 (MMP-9) were detected. Then the data were analyzed by Chi-square test and Fisher's exact test.
RESULTSThe embryo resorption rate in the experimental (8.2%) and normal groups (7.7%) was significantly lower than that of the control (23.5%, P < 0.05). No significant difference was detected between the experimental and normal groups (P > 0.05). The positive expression rates of TGF-beta(1) and PAI-1 proteins in the experimental and normal groups were significantly higher than those in the control group (P < 0.05). The positive expression rate of MMP-9 protein in the experimental and normal groups was significantly lower than that in the control group (P < 0.05). No significant difference in the positive expression rates of the three proteins was detected between the experimental and normal groups (P > 0.05).
CONCLUSIONSBlockage of costimulatory signal CD(86) at early pregnancy can treat uncertain recurrent spontaneous abortion by stimulating the expression of TGF-beta(1), MMP-9 and PAI-1 and reducing the embryo resorption rate.
Abortion, Habitual ; therapy ; Animals ; Antibodies, Monoclonal ; therapeutic use ; B7-2 Antigen ; immunology ; physiology ; Embryo Loss ; prevention & control ; Female ; Immunohistochemistry ; Male ; Matrix Metalloproteinase 9 ; analysis ; Mice ; Mice, Inbred Strains ; Plasminogen Activator Inhibitor 1 ; analysis ; Pregnancy ; Signal Transduction ; Transforming Growth Factor beta1 ; analysis
4.The diagnosis and treatment of hepatic artery complications in 107 cases of orthotopic liver transplantation.
Shu LI ; Ji-ye ZHU ; Guang-ming LI ; Feng-xue ZHU ; Zhan-long SHEN ; Fu-shun WANG ; Ji-run PENG ; Xi-sheng LENG
Chinese Journal of Surgery 2004;42(17):1044-1047
OBJECTIVETo investigate the diagnosis and managements of hepatic artery complications in orthotopic liver transplantation.
METHODSThe clinical data of 107 consecutive orthotopic liver transplantation patients was reviewed retrospectively to assess the risk factors and the diagnosis and treatment of the vascular complications.
RESULTSThe incidence of the artery related complications in orthotopic liver transplantation was associated with the quality of the donor organ artery and the reconstruction way of donor-recipient artery intimately. The main hepatic artery related complications were hepatic artery thrombosis and stenosis. The incidence of the vascular complications was 6.54%, and the mortality rate was 85.7%.
CONCLUSIONSThe main influence factors of vascular complications were the quality of the donor organ artery and the reconstruction way of donor-recipient artery. The key steps of organ salvaging and the patients' life saving were early diagnosis and treatment of those complications.
Adolescent ; Adult ; Aged ; Constriction, Pathologic ; diagnosis ; therapy ; Female ; Hepatic Artery ; pathology ; surgery ; Humans ; Liver Transplantation ; adverse effects ; Male ; Middle Aged ; Retrospective Studies ; Thrombosis ; diagnosis ; therapy ; Transplantation, Homologous
5.Effects of thyroid hormone on myocardial T-type calcium channels at mRNA and protein levels in rats
Run-Xi FU ; Ruo-Song YANG ; Xue-Qin HUANG ; Wen-Ming HE ; You-Yan YU ; Deng-Ming WEI
Chinese Journal of Pathophysiology 2018;34(6):996-1001
AIM:To observe the effect of thyroxine on the expression of T-type calcium channels Cav3. 1, Cav3. 2 and Cav3. 3 in rat myocardium, and to explore the possible biological mechanism between the changes of the ex-pression of T-type calcium channels and the arrhythmia in hyperthyroid heart disease. METHODS:Healthy SD rats (n=20) were randomly divided into normal control group (n=10) and hyperthyroid heart disease group (n=10). The animal model was established by intraperitoneal injection of levothyroxine for 35 d. The contents of T3 and T4 in serum, the heart-to-body weight ratio, the diameter of cardiac myocytes and electrocardiograph were measured to evaluate hyperthyroid heart disease. Moreover, the mRNA and protein expression levels of T-type calcium channels in the myocardium were measured by RT-PCR, immunohistochemistry and Western blot. RESULTS:After intraperitoneal injection of levothyroxine for 35 d, compared with the normal control group, the serum contents of T3 and T4, the heart-to-body weight ratio and the diameter of cardiac myocytes were significantly increased in hyperthyroid heart disease group (P<0.05), and arrhythmia occurred in hyperthyroid heart disease group. By immunohistochemistry and Western blot, the protein expression of Cav3. 1 in-creased significantly (P<0.05), while the protein expression of Cav3.2 decreased significantly (P<0.01). However, no change of the Cav3. 3 protein was observed. The results of RT-PCR were the same as immunohistochemistry and Western blot. CONCLUSION:Thyroxine promotes the expression of Cav3. 1 in the myocardium but inhibits the expression of Cav3. 2 at mRNA and protein levels, which might be involved in arrhythmia in hyperthyroid heart disease.
6.Major causes of death among male steelworkers in Beijing: a prospective study.
Xiu-fang DUAN ; Xi-gui WU ; Xue-hai YU ; Run-ping ZHENG ; Jian-xin LI ; Jian-hua WANG ; Ji-chun CHEN ; Dong-feng GU
Chinese Journal of Cardiology 2006;34(7):651-654
OBJECTIVETo evaluate the major causes of death and risk factors among male steelworkers in Beijing.
METHODSThe study included 5137 men from the cohort of Beijing Capital Steel and Iron Company. The baseline survey was performed in 1974, 1979 and 1980 and the final follow-up evaluation was made in 2001 with a mean follow-up of 20.8 years. Causes of death were coded according to the Ninth Revision of International Classification of Diseases (ICD-9). The mortality was calculated by person-years of follow-up and age-standardized according to the 2000 census data in China. Cox proportional-hazards models adjusting for risk factors were used to estimate the relative risk of death.
RESULTSThere is 760 deaths during follow-up. Age-standardized mortality from all causes was 643.0 per 100,000 person-years. The three leading causes of death were malignant neoplasms (mortality, 231.3 per 100,000 person-years), cerebrovascular diseases (mortality, 139.3 per 100,000 person-years) and heart diseases (mortality, 96.4 per 100,000 person-years). The multivariate-adjusted relative risk of death and the population attributable risk proportion for risk factors were as follow: cigarette smoking (95% CI, 1.174 to 1.765); hypertension (95% CI, 1.370 to 1.904) and hypercholesterolemia (95% CI, 1.057 to 1.537).
CONCLUSIONSOur study indicates that malignant neoplasms, cerebrovascular diseases and heart diseases were major causes of death among male steelworkers. Furthermore, cigarette smoking, hypertension and hypercholesterolemia are leading preventable risk factors for death.
Adolescent ; Adult ; Aged ; Cardiovascular Diseases ; mortality ; Cause of Death ; China ; epidemiology ; Follow-Up Studies ; Humans ; Male ; Metallurgy ; Middle Aged ; Neoplasms ; mortality ; Proportional Hazards Models ; Prospective Studies ; Risk Factors ; Stroke ; mortality
7.Treatment experience of severe acute pancreatitis on 1033 cases..
Wei-Qin LI ; Zhi-Hui TONG ; Zhu-Fu QUAN ; Run-Zhao ZHAO ; Wen-Kui YU ; Xiang-Hong YE ; Zhi-Ming WANG ; Xin-Ying WANG ; Zhong-Qiu WANG ; Da-Xi JI ; Ning LI ; Jie-Shou LI
Chinese Journal of Surgery 2009;47(19):1472-1482
OBJECTIVETo summary the treatment experience of severe acute pancreatitis (SAP).
METHODSFrom January 1997 to March 2009, a total of 1033 patients suffered SAP were admitted with a mean APACHE II score 12.0 +/- 4.3. There were 622 males and 411 females, aged from 13 to 98 years old. All patients were cared by the multidisciplinary team with intensivist, endoscopists, gastroenterologists, radiologist, nephrologist and surgeons.Patients treated in SICU in the early phase of the disease. In these 1033 patients, 365 cases received mechanical ventilation, 218 with tracheotomy, 159 cases received high-volume continuous venovenous hemofiltration (CVVH), 179 received nasobiliary drainage, 513 were treated with early enteral nutrition. CT-guided percutaneous catheter drainge for peripancreatic fluid collection was pefromed for 477 times and 438 patients received surgical debridement for infected pancreatic necrosis.
RESULTSIn all these 1033 cases, 975 patients (94.4%) survived, and 38 patients died (3.7%). The mortality of patients who received surgical debridement for infected pancreatic necrosis was 7.1% (31/438).
CONCLUSIONThe muti-discipline management of severe acute pancreatitis can remarkably improve the prognosis of patients.
Drainage ; Enteral Nutrition ; Hemofiltration ; Humans ; Pancreatitis ; therapy
8.Short-term safety and effects of a novel fully bioabsorable poly-L-lactic acid sirolimus-eluting stents in porcine coronary arteries.
Hong QIU ; Xiao-Ying HU ; Tong LUO ; Bo XU ; Jian XIE ; Xi HU ; Chao-Wei MU ; Chao WU ; Yue TANG ; Ying-Mao RAN ; Xin-Lin XU ; Yan CHU ; Run-Lin GAO
Chinese Medical Journal 2013;126(6):1183-1185
Animals
;
Coronary Vessels
;
surgery
;
Drug-Eluting Stents
;
adverse effects
;
Lactic Acid
;
chemistry
;
Polyesters
;
Polymers
;
chemistry
;
Sirolimus
;
chemistry
;
therapeutic use
;
Swine
9.Long-term clinical outcome of patients with diabetes and chronic total occlusion underwent drug-eluting stents implantation.
Han-jun PEI ; Yong-jian WU ; Yue-jin YANG ; Ji-lin CHEN ; Shu-bin QIAO ; Bo XU ; Jian-jun LI ; Jue CHEN ; Guang-yuan SONG ; Zhen-yan ZHAO ; Xi-mei WANG ; Run-lin GAO
Chinese Journal of Cardiology 2009;37(12):1093-1096
OBJECTIVEThe aim of this study was to assess the long-term clinical outcome of patients with diabetes mellitus and chronic total occlusion (CTO) underwent drug-eluting stents (DES) implantation.
METHODSData of 143 consecutive eligible patients from January, 2006 to May, 2007 were retrospectively analyzed. The endpoint of the study was the major adverse cardiac events (MACE), including death, myocardial infarction, target lesion revascularization. The patients were divided into two groups, event group and non-event group, according to the result of follow-up.
RESULTSLong-term follow-up was finished in 139 (97.2%) patients. Mean follow-up duration was (19.8 + or - 5.1) months. MACE rate was 10.5% during follow-up: 3 deaths, 1 myocardial infarction and 11 repeated target lesion revascularization with PCI. Compared with the non-event group, the percentage of residual lesion [(17.7 + or - 1.8)% vs. (15.4 + or - 5.0)%, P = 0.001] was significantly higher in the event group, however, the final minimal luminal diameter [(2.14 + or - 0.22)% vs. (2.89 + or - 0.37)%, P = 0.004] was lower. Cox regression analysis showed that final luminal diameter (OR: 0.097, 95%CI: 0.013 - 0.694, P = 0.020) was the only dependent predictor at follow-up.
CONCLUSIONFinal minimal luminal diameter is an independent predictor of MACE during follow-up for patients with diabetes and CTO underwent DES implantation.
Adult ; Aged ; Aged, 80 and over ; Blood Vessel Prosthesis Implantation ; Chronic Disease ; Coronary Occlusion ; complications ; diagnosis ; therapy ; Diabetic Angiopathies ; diagnosis ; therapy ; Drug-Eluting Stents ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; Treatment Outcome
10.Lower Baseline LDL Cholesterol Affects All-cause Mortality in Patients with First Percutaneous Coronary Intervention.
Xi CHEN ; Hao CHEN ; Bo LU WEI ; Min ZHANG ; Yuan TAO ; Qing Cheng WANG ; Guo Sheng FU ; Wen Bin ZHANG
Biomedical and Environmental Sciences 2023;36(4):324-333
OBJECTIVE:
Foreign studies have reported that coronary artery disease (CAD) patients with high baseline low-density lipoprotein cholesterol (LDL-C) may have a good prognosis, which is called the "cholesterol paradox". This study aimed to examine whether the "cholesterol paradox" also exists in the Chinese population.
METHODS:
A total of 2,056 patients who underwent the first percutaneous coronary intervention (PCI) between 2014 and 2016 were enrolled in this retrospective cohort study and classified into two groups based on baseline LDL-C = 2.6 mmol/L (100 mg/dL). The outcomes of interest included major adverse cardiovascular events (MACE), all-cause mortality, recurrent nonfatal myocardial infarction, unexpected coronary revascularization, or any nonfatal stroke.
RESULTS:
All-cause mortality occurred in 8 patients (0.7%) from the low-LDL-C group and 12 patients (2.4%) in the high-LDL-C group, with a significant difference between the two groups (adjusted hazard ratio: 4.030, 95% confidence interval: 1.088-14.934; P = 0.037). However, no significant differences existed for the risk of MACE or other secondary endpoints, such as unexpected revascularization, nor any nonfatal stroke in the two groups.
CONCLUSION
In this study, a high baseline LDL-C was not associated with a low risk of clinical outcomes in CAD patients undergoing first PCI, which suggested that the "cholesterol paradox" may be inapplicable to Chinese populations.
Humans
;
Cholesterol, LDL
;
Retrospective Studies
;
Percutaneous Coronary Intervention/adverse effects*
;
Coronary Artery Disease/surgery*
;
Cholesterol
;
Cholesterol, HDL
;
Stroke/etiology*
;
Treatment Outcome
;
Risk Factors